ImageneBio (IMA) Receivables - Accured (2025)

ImageneBio's (IMA) quarterly Receivables - Accured came in at $400000.0 in Q2 2025, up 300.0% quarter-over-quarter from $100000.0 in Q1 2025.

ImageneBio (IMA) Receivables - Accured (2025) Analysis & Trends

ImageneBio has disclosed Receivables - Accured across 1 years of filings, most recently posting $400000.0 for Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acc. Int. Receivables (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	ImageneBio	3.18 Mn	3.18 Mn	-	-

Download Data